Reactions in leprosy patients triggered by COVID‐19 vaccination – a cross‐sectional study from a tertiary care centre in India
- 10 July 2022
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (12) , E971-E972
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Atopic dermatitis exacerbation after Covid‐19 vaccination in Dupilumab‐treated patientsJournal of the European Academy of Dermatology and Venereology, 2022
- Trigger of Type 2 Lepra reaction with acute foot drop following Covid‐19 vaccinationJournal of the European Academy of Dermatology and Venereology, 2022
- Lichen planus flare following COVID‐19 vaccination: A case reportClinical Case Reports, 2021
- Erythema nodosum leprosum and active leprosy after ChAdOx1-S/nCoV-19 recombinant vaccine. A report of two casesLeprosy Review, 2021
- Multibacillary leprosy unmasked by COVID-19 vaccinationJAAD Case Reports, 2021
- Psoriasis exacerbation after COVID‐19 vaccination: a report of 14 cases from a single centreJournal of the European Academy of Dermatology and Venereology, 2021
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responsesNature, 2020
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet, 2020
- Erythema Nodosum Leprosum Triggered by Antecedent Influenza Vaccine and Respiratory Tract Infection: A Case ReportJournal of Cutaneous Medicine and Surgery, 2018
- A Systematic Review of Immunological Studies of Erythema Nodosum LeprosumFrontiers in Immunology, 2017